{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:48:31Z","timestamp":1784832511977,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejogrb.2021.12.001","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T16:44:01Z","timestamp":1638809041000},"page":"110-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Favipiravir exposure and pregnancy outcome of COVID-19 patients"],"prefix":"10.1016","volume":"268","author":[{"given":"Zeynep","family":"T\u0131rm\u0131k\u00e7\u0131o\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejogrb.2021.12.001_b0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40495-021-00253-w","article-title":"Efficacy and safety of new and emerging drugs for COVID-19: Favipiravir and dexamethasone","volume":"7","author":"Sood","year":"2021","journal-title":"Curr Pharmacol Rep"},{"key":"10.1016\/j.ejogrb.2021.12.001_b0010","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijid.2020.10.069","article-title":"Role of favipiravir in the treatment of COVID-19","volume":"102","author":"Joshi","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.12.001_b0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/dmp.2014.151","article-title":"Favipiravir: a new medication for the Ebola virus disease pandemic","volume":"9","author":"Nagata","year":"2015","journal-title":"Disaster Med Public Health Prep"},{"key":"10.1016\/j.ejogrb.2021.12.001_b0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2018.03.003","article-title":"Favipiravir as a potential countermeasure against neglected and emerging RNA viruses","volume":"153","author":"Delang","year":"2018","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.12.001_b0025","first-page":"100159","article-title":"Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019","volume":"2","author":"Louchet","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"s3","key":"10.1016\/j.ejogrb.2021.12.001_b0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12978-017-0429-8","article-title":"Nubia\u2019s mother: Being pregnant in the time of experimental vaccines and therapeutics for Ebola","volume":"14","author":"Caluwaerts","year":"2017","journal-title":"Reprod Health"},{"key":"10.1016\/j.ejogrb.2021.12.001_b0035","unstructured":"Republic of Turkey Ministry of Health, COVID-19 adult patient treatment [updated 2021 May 7] [cited 2021 August 10] Available from https:\/\/covid19.saglik.gov.tr\/TR-66926\/eriskin-hasta-tedavisi.html"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.12.001_b0040","first-page":"354","article-title":"Filiation: A historical term the COVID-19 outbreak recalled in Turkey","volume":"42","author":"Demirta\u015f","year":"2020","journal-title":"Erciyes Med J"},{"key":"10.1016\/j.ejogrb.2021.12.001_b0045","unstructured":"ICD-10 Version:2019 [cited 2021 August 10] Available from https:\/\/icd.who.int\/browse10\/2019\/en#\/Q90-Q99"},{"key":"10.1016\/j.ejogrb.2021.12.001_b0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2431-13-59","article-title":"A systematic review and metaanalysis to revise the Fenton growth chart for premature infants","volume":"13","author":"Fenton","year":"2013","journal-title":"BMC Pediatr"},{"issue":"1\u201314","key":"10.1016\/j.ejogrb.2021.12.001_b0055","first-page":"Turkish","article-title":"Reference values for body weight, height, head circumference and body mass index in Turkish children","volume":"51","author":"Neyzi","year":"2008","journal-title":"Cocuk Sagligi ve Hastaliklari Derg"},{"key":"10.1016\/j.ejogrb.2021.12.001_b0060","series-title":"Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment","first-page":"159","author":"Schaefer","year":"2015"},{"issue":"S1","key":"10.1016\/j.ejogrb.2021.12.001_b0065","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4755-10-S1-S2","article-title":"Born too soon preterm birth action group. Born too soon: theglobal epidemiology of 15 million preterm births","volume":"10","author":"Blencowe","year":"2013","journal-title":"Reprod Health"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.12.001_b0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1728-4465.2014.00393.x","article-title":"Intended and unintended pregnancies worldwide in 2012 and recent trends","volume":"45","author":"Sedgh","year":"2014","journal-title":"Stud Fa. Plann"},{"key":"10.1016\/j.ejogrb.2021.12.001_b0075","unstructured":"National Institutes of Health. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [cited 2021 August 10] Available from https:\/\/covid19treatmentguidelines.nih.gov\/"},{"key":"10.1016\/j.ejogrb.2021.12.001_b0080","series-title":"Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment","first-page":"10","author":"Schaefer","year":"2015"},{"issue":"23","key":"10.1016\/j.ejogrb.2021.12.001_b0085","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1136\/heartjnl-2015-307639","article-title":"Patent foramen ovale: the current state of play","volume":"101","author":"Asrress","year":"2015","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.ejogrb.2021.12.001_b0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bj.2019.12.007","article-title":"Investigation of echocardiographic characteristics and predictors for persistent defects of patent foramen ovale or patent ductus arteriosus in Chinese newborns","volume":"44","author":"Yuan","year":"2021","journal-title":"Biomed J"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.12.001_b0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0301-2115(99)00075-5","article-title":"Perinatal outcome and peripartum complications in preterm singleton and twins\u2019 deliveries: a comparative study","volume":"87","author":"Mizrahi","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.12.001_b0100","doi-asserted-by":"crossref","first-page":"73.e1","DOI":"10.1016\/j.ajog.2015.02.020","article-title":"Neonatal outcome of very preterm twins: policy of planned vaginal or cesarean delivery","volume":"213","author":"Sentilhes","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.ejogrb.2021.12.001_b0105","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1471-0528.2005.00631.x","article-title":"Mode of delivery and the risk of delivery-related perinatal death among twins at term: a retrospective cohort study of 8073 births","volume":"112","author":"Smith","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2021.12.001_b0110","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1034\/j.1600-0412.2001.080008731.x","article-title":"Mode of delivery in breech presentation at term: increased neonatal morbidity with vaginal delivery","volume":"80","author":"Herbst","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2021.12.001_b0115","doi-asserted-by":"crossref","unstructured":"Huber-Krum S, Karadon D, Kurutas S, et al. Estimating abortion prevalence and understanding perspectives of community leaders and providers: Results from a mixed-method study in Istanbul, Turkey. Women's Health 2020;16: 1745506520953353.","DOI":"10.1177\/1745506520953353"},{"issue":"01","key":"10.1016\/j.ejogrb.2021.12.001_b0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0030-1267080","article-title":"Loss to follow-up","volume":"2","author":"Dettori","year":"2011","journal-title":"Evid Based Spine Care J"},{"issue":"3","key":"10.1016\/j.ejogrb.2021.12.001_b0125","doi-asserted-by":"crossref","first-page":"298","DOI":"10.24953\/turkjped.2018.03.010","article-title":"Birth outcomes after inadvertent use of category X drugs contraindicated in pregnancy: Where is the real risk?","volume":"60","author":"Ozturk","year":"2018","journal-title":"Turk J Pediatr"},{"issue":"1","key":"10.1016\/j.ejogrb.2021.12.001_b0130","article-title":"Perception of teratogenic and foetotoxic risk by health professionals: a survey in Midi-Pyrenees area","volume":"6","author":"Damase-Michel","year":"2008","journal-title":"Pharm Pract"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521010009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211521010009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T16:11:17Z","timestamp":1733760677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211521010009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":26,"alternative-id":["S0301211521010009"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.12.001","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Favipiravir exposure and pregnancy outcome of COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2021.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}